You just read:

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related Psychosis

News provided by

Medical Marijuana, Inc.

Aug 03, 2017, 09:00 ET